<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Experts urge FDA to set clear safety and access standards for psychedelic drugs — Live Feed</title><link>https://www.live-feeds.com/feed/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Experts Press FDA to Set Psychedelic Drug Standards</title><link>https://www.live-feeds.com/feed/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs</link><guid isPermaLink="false">https://www.live-feeds.com/feed/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs#u70077</guid><pubDate>Wed, 16 Sep 2026 09:21:24 +0000</pubDate><description>Federal health officials and industry stakeholders gathered for a public hearing to debate safety, access, and treatment standards for psychedelic therapies. The four-hour session in Silver Spring, Maryland, featured testimony from eighty invited witnesses, including doctors, pharmacists, and veterans, each granted two minutes to speak. Discussions centered on how the agency will regulate these compounds for conditions like PTSD and depression as a potential approval looms. Officials laid out plans to make therapies available more quickly while adhering to strict scientific standards.Why it ma</description></item>
</channel></rss>